Real clinical experience after one year of treatment with tolvaptan in patients with autosomal dominant polycystic kidney disease.
Naranjo J, Borrego F, Rocha JL, Salgueira M, Martín-Gomez MA, Orellana C, Morales A, Vallejo F, Hidalgo P, Rodríguez F, Garófano R, González I, Esteban R, Espinosa M.
Naranjo J, et al. Among authors: martin gomez ma.
Front Med (Lausanne). 2022 Sep 29;9:987092. doi: 10.3389/fmed.2022.987092. eCollection 2022.
Front Med (Lausanne). 2022.
PMID: 36250074
Free PMC article.